Out-licensing: Diagnostic & Infectious Diseases

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 11..20 of 248 - per page Previous page Next page
Order by

Human Neutralizing Monoclonal Antibodies to Respiratory Syncytial Virus and Human Neutralizing Antibodies to Respiratory Syncytial Virus

A human monoclonal antibody fragment (Fab) discovered utilizing phage display technology More

T-Cell Enumeration Using Dried Blood Spots as a Surrogate for CD4+ T-Cell Counts to Monitor HIV+ Patients

Novel method provides a superior functional assay for HIV disease staging that does not require cold storage or fresh sample processing. More

Swine Hepatitis E Virus Available For Use in Diagnosis, Prevention and Treatment of Hepatitis E

A mechanism for augmenting the immune response against HEV in infected individuals More

Assay for Identification of Influenza-Neutralizing Antibodies

A system to quantitate virus neutralization and entry, utilizing pseudotyped lentiviral vectors that mimic properties of the influenza virus. More

Immunogenic T Cell Targets in Autoimmune Hepatitis and Methods of Use

New methods of diagnosing and monitoring the progression or response to therapy of subjects with autoimmune hepatitis More

Treatment and Diagnosis of Cancer, Diabetes and Other Disorders Using Adrenomedullin Peptides and Antibodies

Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More

Epstein-Barr Negative Lymphoma-Derived Cell Lines

These cell lines have been used to advance understanding of the molecular mechanisms of lymphomagenesis, and may be useful for the identification of molecular targets for agents that can be developed for the treatment of lymphomas and other tumors. More

Broadly Cross-Reactive Neutralizing Antibodies against Human Immunodeficiency Virus Selected by ENV-CD4-CO-Receptor Complexes

Novel anti-HIV human monoclonal antibody exhibits a unique binding activity compared to its counterparts. More

Modified Sugar Substrates and Methods of Use

Methods and compositions for making and using functionalized sugars More

Improved Method for Analysis of Microarray and Other Multidimensional Data

Improved accuracy in pattern recognition of clustered multidimensional data More

Displaying 11..20 of 248 - per page Previous page Next page
Order by

Your selection

Industry sector: Diagnostic del
Therapeutic target: Infectious diseases del

Browse By

Industry sector: Antibody-based diagnostics; Biomarker-based diagnostics; CAT; Genetic diagnostics; Imaging; MRI; Nuclear medicine; Other; Self-test systems; Supplies; Test systems; Ultrasound; X-ray
Therapeutic target: Bacteria or virus; Bioterrorism; Diseases; Hepatitis (other); Nosocomial infections; Parasitic diseases; Treatments
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Pay-per-Click	Company Profiling	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us